Liposomal formulation of a gold(<scp>iii</scp>) metalloantibiotic: a promising strategy against antimicrobial resistance-Reference-Cited by-同舟云学术

Liposomal formulation of a gold(iii) metalloantibiotic: a promising strategy against antimicrobial resistance

Published:2024 Issue: Volume: Page:
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Llamedo Alejandro¹²,Rodríguez Pablo¹,Gabasa Yaiza³⁴,Soengas Raquel G.²^ORCID,Rodríguez-Solla Humberto²^ORCID,Elorriaga David²^ORCID,García-Alonso Francisco J.²,Soto Sara M.³⁴

Affiliation:

1. Nanovex Biotechnologies S.L., Parque Tecnológico de Asturias Edificio CEEI, 33428 Llanera, Spain

2. Departamento de Química Orgánica e Inorgánica, Instituto Universitario de Química Organometálica “Enrique Moles”, Universidad de Oviedo, Julián Clavería 8, 33006 Oviedo, Spain

3. ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

4. CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain

Abstract

A novel gold(iii) metalloantibiotic liposomal formulation was developed. The nanoformulation show high stability and suitable properties for drug delivery, representing a promising strategy to fight against drug-resistant bacteria.

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/DT/D4DT01867B

Reference64 articles.

1. Antimicrobial Resistance and Its Drivers—A Review

2. Molecular mechanisms of antibiotic resistance revisited

3. An overview of antibiotic and antibiotic resistance

4. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

5. The negative impact of antibiotic resistance